V. Sanna

发表

Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.

S. Srivastava, Gurvinder Singh, Anu T. Singh, 2007, Journal of medicinal chemistry.

Identification of 1,2,4-Oxadiazoles-Based Novel EGFR Inhibitors: Molecular Dynamics Simulation-Guided Identification and in vitro ADME Studies

Kaushal P. Patel, Shishir Rohit, V. Sanna, 2022, OncoTargets and therapy.

Evaluation Of 5-hydroxy-2,3-diaryl (substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anti angiogenic and anticancer agents

A. Burman, M. Jaggi, V. Sanna, 2010, Investigational New Drugs.

Synthesis and cytotoxic activity of heterocyclic ring-substituted betulinic acid derivatives.

P. Sharma, Vivek Kumar, Anu T. Singh, 2008, Bioorganic & medicinal chemistry letters.

Bombesin analogs containing α‐amino‐isobutyric acid with potent anticancer activity

Anu T. Singh, R. Mukherjee, M. Jaggi, 2007 .

Discovery of novel tetrahydrobenzo[b]thiophene-3-carbonitriles as histone deacetylase inhibitors.

Piyush A. Gediya, L. Altucci, T. Kurohara, 2021, Bioorganic chemistry.

1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.

P. Sharma, Vivek Kumar, Anu T. Singh, 2009, European journal of medicinal chemistry.

Rational design-aided discovery of novel 1,2,4-oxadiazole derivatives as potential EGFR inhibitors.

Sanjay K. Singh, Shishir Rohit, V. Sanna, 2021, Bioorganic chemistry.

Synthesis of 13-amino costunolide derivatives as anticancer agents.

S. Srivastava, Gurvinder Singh, Anu T. Singh, 2006, Bioorganic & medicinal chemistry letters.

Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas

Gurvinder Singh, Anu T. Singh, R. Mukherjee, 2008, Investigational New Drugs.